Pacific Biosciences of California, Inc.
MX ˙ BMV ˙ US69404D1081
SecurityMX:PACB / Pacific Biosciences of California, Inc.
InstitutionRockefeller Capital Management L.P.
Latest Disclosed Ownership5,198 shares
Latest Disclosed Value $ 6,862
Rockefeller Capital Management L.P. reports 317.17% increase in ownership of PACB / Pacific Biosciences of California, Inc.

On May 14, 2026 - Rockefeller Capital Management L.P. filed a 13F-HR form disclosing ownership of 5,198 shares of Pacific Biosciences of California, Inc. (MX:PACB) valued at $6,862 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on March 16, 2026 disclosing 1,246 shares of Pacific Biosciences of California, Inc.. This represents a change in shares of 317.17% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 5,198 3,952 317.17 7 200.00 0.0000
2026-03-16 2025-12-31 13F/A-1 PACIFIC BIOSCIENCES CALIF IN COM 69404D108 1,246 989 384.82 2 0.0000
2026-02-14 2025-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 1,246 989 2 0.0000
2025-11-14 2025-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 257 257 0 0.0000
2023-05-17 2023-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 0 -1,018 -100.00 0 -100.00
2023-03-06 2022-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 1,018 527 107.33 8 300.00 0.0000
2022-11-02 2022-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 491 -826 -62.72 2 -50.00 0.0000
2022-08-12 2022-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 1,317 -75,579 -98.29 4 -99.43 0.0000
2022-05-13 2022-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 76,896 76,582 24,389.17 699 13,880.00 0.0034
2022-02-14 2021-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 314 314 5 0.0000
2021-11-12 2021-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 0 -4,413 -100.00 0 -100.00
2021-08-10 2021-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 4,413 -461 -9.46 153 -4.97 0.0009
2021-05-11 2021-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 4,874 -1,456 -23.00 161 -1.83 0.0011
2021-02-12 2020-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 6,330 6,330 164 0.0012
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.